Real‐world use of adjunctive perampanel for focal‐onset seizures in Italy: A mirroring clinical practice study of perampanel in adults and adolescents ( AMPA )

Documenti analoghi

• Efficacy and safety of perampanel in patients with seizures associated with Lennox–Gastaut syndrome: A randomized trial
  di: David G. Vossler, et al.
  Pubblicazione: (2024)
• Efficacy and safety of perampanel as first adjunctive therapy in patients with focal‐onset seizures or generalized tonic‐clonic seizures in four post‐marketing studies across regions
  di: Stefano Meletti, et al.
  Pubblicazione: (2025)
• Long‐term safety and efficacy of adjunctive perampanel in pediatric patients (ages 4 to <12 years) with inadequately controlled focal‐onset seizures or generalized tonic–clonic seizures
  di: Robert Flamini, et al.
  Pubblicazione: (2025)
• Response to amoxicillin and perampanel in infantile Alexander disease
  di: Susana Boronat, et al.
  Pubblicazione: (2024)
• Serum perampanel levels in patients with seizures are not affected by hemodialysis
  di: Yusuke Nakazawa, et al.
  Pubblicazione: (2024)